
Did the health authorities withhold crucial information
A growing part of the world public is convinced that the covid-19 pandemic was not only a health crisis, but also a period of concealment of information, increased control of public discourse and the influence of pharmaceutical interests on the decisions of health authorities. While reticence and silence on these issues still prevail in most countries, critics point to the political legacy of the pandemic era, which is said to have entrenched the use of fear, surveillance and curtailment of dissent. That is why the issue of transparency and responsibility of health institutions remains one of the central political and professional disputes of our time.
In the US, these issues have intensified again in recent months. Republican senators leading investigations into the handling of the Covid-19 pandemic have accused some public health agencies (FDA, CDC, NIAID/NIH and others) of a lack of transparency – even deliberate cover-up and slow response to reports of suspected adverse, even fatal, outcomes from vaccinations. These agencies, on the other hand, point out that data from the VAERS system, the US database for reporting adverse reactions after vaccination, is often misinterpreted. It is a voluntary reporting system in which anyone can report a health event after vaccination, which in itself does not imply a causal link with the vaccine. In their opinion, without additional expert analysis, such data do not allow conclusions about safety or risks, but serve primarily as an early warning system, which is well known. Therefore, the senators point out that by April 2026, more than 1.6 million adverse events have been reported after vaccination against covid-19, including approximately 39,000 deaths and tens of thousands of cases of serious complications such as myocarditis and pericarditis. In their opinion, such figures justify significantly more thorough and independent investigations and a re-evaluation of the conduct of health institutions during the pandemic.
Critics note with some irony that vaccines have been presented to the public as safe and effective enough for use on billions of people, while at the same time their manufacturers have secured special forms of legal protection against possible compensation claims in many countries. Such an arrangement in the work of the public raises questions about the relationship between responsibility, risk and profit during a pandemic.
The article is accessible only to subscribers
The article is accessible only to subscribers















